Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEPEC Platform Trial in Critical Care
NCT06605144Phase 3Recruiting
- Sponsor
- Université de Sherbrooke
- Start
- Mar 2025
- Primary completion
- Dec 2029
- Countries
- 3
01
Overview
A Phase 3 trial of Platelet Gel in critical illness, Shock, Thrombocytopenia, hypotension, sponsored by Université de Sherbrooke. Started Mar 2025; status: recruiting.
02
Drugs
Platelet Gel
03
Conditions
critical illnessShockThrombocytopeniahypotension
Beyond the preview
Go deeper on NCT06605144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605144.